{
    "hands_on_practices": [
        {
            "introduction": "Quantitative Systems Pharmacology begins with a firm grasp of pharmacokinetics (PK), the study of what the body does to a drug. This exercise takes you back to first principles, challenging you to construct a one-compartment PK model directly from the law of mass balance, rather than starting with a pre-made equation. Mastering this foundational skill  is essential for building and interpreting the more complex, multi-scale models that are the hallmark of QSP.",
            "id": "3923515",
            "problem": "A single-dose drug is administered using a constant-rate intravenous infusion into a well-stirred physiological compartment that is appropriately modeled as a one-compartment pharmacokinetic system. Assume linear (first-order) elimination and instantaneous mixing. Let the compartment have volume of distribution $V$ and systemic clearance $CL$, and let the infusion proceed at a constant rate $R_0$ (amount per unit time). The infusion is run sufficiently long that at time $t=0$ the system is at steady state, after which the infusion is instantaneously stopped. \n\nUsing only the law of mass balance as the fundamental starting point and the definitions of first-order elimination and concentration, perform the following:\n\n1. Starting from mass balance, write the ordinary differential equation (ODE) for the amount of drug $A(t)$ in the compartment during the infusion and after the infusion stops. Convert each ODE to one in terms of the concentration $C(t)$ using $C(t)=A(t)/V$.\n\n2. Solve the ODE for the case of constant infusion starting at $t=0$ with $C(0)=0$, and use your solution to identify the steady-state concentration as $t \\to \\infty$.\n\n3. Using the fact that $t=0$ marks the instant of infusion stop after steady state has been reached, solve for the concentration trajectory $C(t)$ for $t \\ge 0$ after infusion stop.\n\nExpress your final answer as a single closed-form analytic expression for $C(t)$ for $t \\ge 0$ after the infusion has stopped, in terms of $R_0$, $V$, $CL$, and $t$. Do not include units in your final boxed expression. You may assume all parameters are positive constants and that the model assumptions hold exactly. The final answer must be a single expression, not a piecewise definition.",
            "solution": "The problem requires the derivation and solution of a one-compartment pharmacokinetic model, starting from the fundamental law of mass balance. The process will be carried out in three main steps as requested: derivation of the governing ordinary differential equations (ODEs), determination of the steady-state concentration during infusion, and finally, solving for the concentration profile after the infusion is stopped.\n\n**Step 1: Derivation of the Governing ODEs**\n\nThe law of mass balance for the amount of drug, $A(t)$, in the compartment at time $t$ is stated as:\n$$\n\\frac{dA(t)}{dt} = \\text{Rate of drug input} - \\text{Rate of drug elimination}\n$$\n\nThe rate of drug elimination is stated to be a first-order process. This means the rate of elimination is directly proportional to the amount of drug present, $A(t)$. We can write this as $\\text{Rate of elimination} = k_e A(t)$, where $k_e$ is the first-order elimination rate constant.\n\nThe problem provides the parameter systemic clearance, $CL$. Clearance is defined as the volume of physiological fluid cleared of drug per unit time. Therefore, the rate of elimination can also be expressed as the product of clearance and the drug concentration, $C(t)$:\n$$\n\\text{Rate of elimination} = CL \\cdot C(t)\n$$\nBy definition, the concentration is the amount of drug per unit volume of distribution, $V$:\n$$\nC(t) = \\frac{A(t)}{V} \\implies A(t) = V \\cdot C(t)\n$$\nEquating the two expressions for the rate of elimination gives a relationship between $k_e$, $CL$, and $V$:\n$$\nk_e A(t) = CL \\cdot C(t)\n$$\nSubstituting $A(t) = V \\cdot C(t)$:\n$$\nk_e (V \\cdot C(t)) = CL \\cdot C(t) \\implies k_e = \\frac{CL}{V}\n$$\nWe will use this established relationship. The rate of elimination is thus $\\frac{CL}{V} A(t)$.\n\nNow, we can write the ODE for the amount of drug, $A(t)$, for the two phases:\n\n1.  **During constant-rate infusion:** The rate of drug input is a constant, $R_0$. The mass balance equation is:\n    $$\n    \\frac{dA(t)}{dt} = R_0 - \\frac{CL}{V} A(t)\n    $$\n2.  **After the infusion stops:** The rate of drug input is $0$. The mass balance equation is:\n    $$\n    \\frac{dA(t)}{dt} = - \\frac{CL}{V} A(t)\n    $$\n\nNext, we convert these ODEs for the amount $A(t)$ into ODEs for the concentration $C(t)$. Since $A(t) = V \\cdot C(t)$ and $V$ is a constant, we have $\\frac{dA(t)}{dt} = V \\frac{dC(t)}{dt}$.\n\n1.  **During infusion:** Substituting into the first ODE:\n    $$\n    V \\frac{dC(t)}{dt} = R_0 - \\frac{CL}{V} (V \\cdot C(t))\n    $$\n    $$\n    V \\frac{dC(t)}{dt} = R_0 - CL \\cdot C(t)\n    $$\n    Dividing by $V$:\n    $$\n    \\frac{dC(t)}{dt} = \\frac{R_0}{V} - \\frac{CL}{V} C(t)\n    $$\n2.  **After infusion stops:** Substituting into the second ODE:\n    $$\n    V \\frac{dC(t)}{dt} = - \\frac{CL}{V} (V \\cdot C(t))\n    $$\n    $$\n    V \\frac{dC(t)}{dt} = - CL \\cdot C(t)\n    $$\n    Dividing by $V$:\n    $$\n    \\frac{dC(t)}{dt} = - \\frac{CL}{V} C(t)\n    $$\n\n**Step 2: Determination of the Steady-State Concentration**\n\nTo find the steady-state concentration, $C_{\\text{ss}}$, we analyze the system during the infusion phase. Steady state is achieved when the concentration no longer changes with time, i.e., $\\frac{dC(t)}{dt} = 0$. Setting the derivative in the infusion ODE to zero:\n$$\n0 = \\frac{R_0}{V} - \\frac{CL}{V} C_{\\text{ss}}\n$$\nSolving for $C_{\\text{ss}}$:\n$$\n\\frac{CL}{V} C_{\\text{ss}} = \\frac{R_0}{V} \\implies C_{\\text{ss}} = \\frac{R_0}{CL}\n$$\nAlternatively, one could solve the ODE for the infusion phase, $\\frac{dC}{dt} + \\frac{CL}{V} C = \\frac{R_0}{V}$, with the initial condition $C(0) = 0$. The solution to this first-order linear ODE is $C(t) = \\frac{R_0}{CL} \\left(1 - \\exp\\left(-\\frac{CL}{V}t\\right)\\right)$. Taking the limit as $t \\to \\infty$ gives the steady-state concentration:\n$$\nC_{\\text{ss}} = \\lim_{t \\to \\infty} \\left[ \\frac{R_0}{CL} \\left(1 - \\exp\\left(-\\frac{CL}{V}t\\right)\\right) \\right] = \\frac{R_0}{CL}(1 - 0) = \\frac{R_0}{CL}\n$$\nBoth methods yield the same result for the steady-state concentration.\n\n**Step 3: Solution for Concentration After Infusion Stop**\n\nThe problem states that at time $t=0$, the infusion is stopped, and the system is at steady state. This defines the initial condition for the post-infusion phase. The concentration at $t=0$ is the steady-state concentration derived in the previous step:\n$$\nC(0) = C_{\\text{ss}} = \\frac{R_0}{CL}\n$$\nThe governing ODE for $t \\ge 0$ is the one for the post-infusion phase:\n$$\n\\frac{dC(t)}{dt} = - \\frac{CL}{V} C(t)\n$$\nThis is a separable first-order ODE. We can write it as:\n$$\n\\frac{dC}{C} = -\\frac{CL}{V} dt\n$$\nIntegrating both sides from the initial time $t=0$ to a later time $t$, and correspondingly from the initial concentration $C(0)$ to $C(t)$:\n$$\n\\int_{C(0)}^{C(t)} \\frac{1}{C'} dC' = \\int_{0}^{t} -\\frac{CL}{V} dt'\n$$\n$$\n[\\ln|C'|]_{C(0)}^{C(t)} = -\\frac{CL}{V} [t']_{0}^{t}\n$$\n$$\n\\ln(C(t)) - \\ln(C(0)) = -\\frac{CL}{V} t\n$$\nSince concentration must be non-negative, the absolute value is not needed.\n$$\n\\ln\\left(\\frac{C(t)}{C(0)}\\right) = -\\frac{CL}{V} t\n$$\nExponentiating both sides:\n$$\n\\frac{C(t)}{C(0)} = \\exp\\left(-\\frac{CL}{V} t\\right)\n$$\n$$\nC(t) = C(0) \\exp\\left(-\\frac{CL}{V} t\\right)\n$$\nSubstituting the initial condition $C(0) = \\frac{R_0}{CL}$:\n$$\nC(t) = \\frac{R_0}{CL} \\exp\\left(-\\frac{CL}{V} t\\right)\n$$\nThis is the final closed-form analytic expression for the drug concentration $C(t)$ for $t \\ge 0$ after the infusion has stopped, expressed in terms of the given parameters $R_0$, $V$, $CL$, and time $t$.",
            "answer": "$$\\boxed{\\frac{R_0}{CL} \\exp\\left(-\\frac{CL}{V} t\\right)}$$"
        },
        {
            "introduction": "While linear models are a useful starting point, biological systems are inherently nonlinear. This practice introduces a core technique from dynamical systems theory—stability analysis—applied to a model of drug-receptor interaction. By finding the system's equilibrium point and analyzing its local stability using the Jacobian matrix , you will learn how to mathematically determine whether a drug's effect will be stable or prone to oscillations, a critical consideration in drug development.",
            "id": "3923494",
            "problem": "Consider a minimal Quantitative Systems Pharmacology (QSP) model of a monoclonal antibody (drug) interacting with a cell-surface receptor. Let $C(t)$ denote the free drug concentration (nanomolar, $\\mathrm{nM}$) in a well-mixed central compartment and $R(t)$ denote the free receptor concentration (nanomolar, $\\mathrm{nM}$). The drug is infused at a zero-order rate, is eliminated with a first-order rate constant, and binds the receptor with bilinear kinetics. The receptor is synthesized at a zero-order rate, degraded with a first-order rate constant, and is depleted by drug binding. The system is described by the following nonlinear Ordinary Differential Equations (ODEs):\n$$\n\\frac{dC}{dt} \\;=\\; k_{\\mathrm{in}} \\;-\\; k_{\\mathrm{el}}\\,C \\;-\\; k_{b}\\,C\\,R,\n$$\n$$\n\\frac{dR}{dt} \\;=\\; k_{\\mathrm{syn}} \\;-\\; k_{\\mathrm{deg}}\\,R \\;-\\; k_{b}\\,C\\,R,\n$$\nwhere $k_{\\mathrm{in}}$ is a zero-order input (units $\\mathrm{nM}\\cdot \\mathrm{h}^{-1}$), $k_{\\mathrm{el}}$ is the drug first-order elimination rate constant (units $\\mathrm{h}^{-1}$), $k_{\\mathrm{syn}}$ is the receptor zero-order synthesis rate (units $\\mathrm{nM}\\cdot \\mathrm{h}^{-1}$), $k_{\\mathrm{deg}}$ is the receptor first-order degradation rate constant (units $\\mathrm{h}^{-1}$), and $k_b$ is the drug-receptor binding rate parameter (units $\\mathrm{nM}^{-1}\\cdot \\mathrm{h}^{-1}$). Consider the parameter values\n$$\nk_{\\mathrm{in}} \\,=\\, 3,\\quad k_{\\mathrm{el}} \\,=\\, 1,\\quad k_{\\mathrm{syn}} \\,=\\, 2,\\quad k_{\\mathrm{deg}} \\,=\\, 1,\\quad k_b \\,=\\, 1.\n$$\nDefine an equilibrium point $(C^{\\ast},R^{\\ast})$ of the system as a constant pair satisfying $\\frac{dC}{dt}=0$ and $\\frac{dR}{dt}=0$. Using foundational definitions from dynamical systems and linearization theory, determine the physically relevant positive equilibrium $(C^{\\ast},R^{\\ast})$, construct the Jacobian matrix $J(C^{\\ast},R^{\\ast})$, and compute its eigenvalues. Finally, report the spectral abscissa $\\alpha(J(C^{\\ast},R^{\\ast}))$, defined as the maximum real part among the eigenvalues of $J(C^{\\ast},R^{\\ast})$. Express your final result in $\\mathrm{h}^{-1}$ and round your answer to four significant figures.",
            "solution": "The problem asks for a stability analysis of a two-variable nonlinear system describing drug-receptor interaction at an equilibrium point.\n\n**Step 1: Find the Physically Relevant Equilibrium Point**\n\nAn equilibrium point $(C^{\\ast},R^{\\ast})$ is found by setting the time derivatives to zero:\n$$\n\\frac{dC}{dt} = 3 - C - C R = 0 \\quad (1)\n$$\n$$\n\\frac{dR}{dt} = 2 - R - C R = 0 \\quad (2)\n$$\nFrom (1) and (2), we can equate the $C R$ terms:\n$$\n3 - C^{\\ast} = 2 - R^{\\ast} \\implies C^{\\ast} = R^{\\ast} + 1\n$$\nSubstitute this into equation (2):\n$$\n2 - R^{\\ast} - (R^{\\ast} + 1)R^{\\ast} = 0\n$$\n$$\n2 - R^{\\ast} - (R^{\\ast})^2 - R^{\\ast} = 0\n$$\n$$\n(R^{\\ast})^2 + 2R^{\\ast} - 2 = 0\n$$\nUsing the quadratic formula, $R^{\\ast} = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$:\n$$\nR^{\\ast} = \\frac{-2 \\pm \\sqrt{2^2 - 4(1)(-2)}}{2(1)} = \\frac{-2 \\pm \\sqrt{12}}{2} = -1 \\pm \\sqrt{3}\n$$\nFor a physically relevant concentration, we must have $R^{\\ast} > 0$. Therefore, we choose the positive root:\n$$\nR^{\\ast} = \\sqrt{3} - 1\n$$\nThe corresponding drug concentration is:\n$$\nC^{\\ast} = R^{\\ast} + 1 = (\\sqrt{3} - 1) + 1 = \\sqrt{3}\n$$\nThe physically relevant positive equilibrium point is $(C^{\\ast},R^{\\ast}) = (\\sqrt{3}, \\sqrt{3}-1)$.\n\n**Step 2: Construct and Evaluate the Jacobian Matrix**\n\nThe Jacobian matrix $J$ is given by the partial derivatives of the system's functions, $f_1(C, R) = 3 - C - CR$ and $f_2(C, R) = 2 - R - CR$:\n$$\nJ(C, R) = \\begin{pmatrix} \\frac{\\partial f_1}{\\partial C} & \\frac{\\partial f_1}{\\partial R} \\\\ \\frac{\\partial f_2}{\\partial C} & \\frac{\\partial f_2}{\\partial R} \\end{pmatrix} = \\begin{pmatrix} -1 - R & -C \\\\ -R & -1 - C \\end{pmatrix}\n$$\nEvaluating this matrix at the equilibrium point $(C^{\\ast},R^{\\ast}) = (\\sqrt{3}, \\sqrt{3}-1)$:\n$$\nJ(C^{\\ast}, R^{\\ast}) = \\begin{pmatrix} -1 - (\\sqrt{3}-1) & -\\sqrt{3} \\\\ -(\\sqrt{3}-1) & -1 - \\sqrt{3} \\end{pmatrix} = \\begin{pmatrix} -\\sqrt{3} & -\\sqrt{3} \\\\ 1-\\sqrt{3} & -1-\\sqrt{3} \\end{pmatrix}\n$$\n\n**Step 3: Compute Eigenvalues and the Spectral Abscissa**\n\nThe eigenvalues $\\lambda$ are the roots of the characteristic equation $\\det(J - \\lambda I) = 0$, which for a 2x2 matrix is $\\lambda^2 - \\mathrm{tr}(J)\\lambda + \\det(J) = 0$.\n\nThe trace of the Jacobian is:\n$$\n\\mathrm{tr}(J) = (-\\sqrt{3}) + (-1 - \\sqrt{3}) = -1 - 2\\sqrt{3}\n$$\nThe determinant of the Jacobian is:\n$$\n\\det(J) = (-\\sqrt{3})(-1 - \\sqrt{3}) - (-\\sqrt{3})(1 - \\sqrt{3}) = (\\sqrt{3} + 3) - (-\\sqrt{3} + 3) = 2\\sqrt{3}\n$$\nThe characteristic equation is:\n$$\n\\lambda^2 - (-1 - 2\\sqrt{3})\\lambda + 2\\sqrt{3} = 0\n$$\n$$\n\\lambda^2 + (1 + 2\\sqrt{3})\\lambda + 2\\sqrt{3} = 0\n$$\nThis equation can be factored as $(\\lambda + 1)(\\lambda + 2\\sqrt{3}) = 0$.\nThe eigenvalues are therefore:\n$$\n\\lambda_1 = -1 \\quad \\text{and} \\quad \\lambda_2 = -2\\sqrt{3}\n$$\nThe spectral abscissa $\\alpha(J)$ is the maximum of the real parts of the eigenvalues. Since both eigenvalues are real, we have:\n$$\n\\alpha(J) = \\max\\{-1, -2\\sqrt{3}\\} = -1\n$$\nThe units of the eigenvalues are inverse time, $\\mathrm{h}^{-1}$.\n\n**Step 4: Final Answer**\n\nRounding the result to four significant figures gives:\n$$\n\\alpha(J(C^{\\ast},R^{\\ast})) = -1.000\\ \\mathrm{h}^{-1}\n$$",
            "answer": "$$\n\\boxed{-1.000}\n$$"
        },
        {
            "introduction": "We now integrate our skills to dissect a more realistic and clinically vital model for biologic drugs like monoclonal antibodies. This exercise explores the dynamics of Target-Mediated Drug Disposition (TMDD), where the drug's distribution and elimination are significantly influenced by its binding to a pharmacological target. You will analyze how different kinetic processes, particularly the slow turnover of the target receptor versus the fast binding of the drug, interact to govern the overall system behavior and the duration of the drug's effect .",
            "id": "3923490",
            "problem": "Consider a standard Target-Mediated Drug Disposition (TMDD) model in quantitative systems pharmacology for a monoclonal antibody binding a cell-surface receptor. Let $R(t)$ denote free receptor concentration, $C(t)$ denote free drug concentration, and $RC(t)$ denote receptor–drug complex concentration. The receptor is synthesized and degraded with constant rates $k_{\\text{syn}}$ and $k_{\\text{deg}}$, respectively. Binding and unbinding follow mass-action kinetics with association rate $k_{\\text{on}}$ and dissociation rate $k_{\\text{off}}$. Complex internalization occurs with rate $k_{\\text{int}}$. Neglect receptor recycling and drug elimination from the complex other than via internalization. The governing mass-action ordinary differential equations are\n$$\\frac{dR}{dt} \\;=\\; k_{\\text{syn}} \\;-\\; k_{\\text{deg}}\\,R \\;-\\; k_{\\text{on}}\\,C\\,R \\;+\\; k_{\\text{off}}\\,RC,$$\n$$\\frac{d(RC)}{dt} \\;=\\; k_{\\text{on}}\\,C\\,R \\;-\\; \\big(k_{\\text{off}} + k_{\\text{int}}\\big)\\,RC.$$\nBefore drug administration, assume $C(t)=0$ and the system is at steady state with $R(t)=R_{\\text{ss}}$ and $RC(t)=0$, where $R_{\\text{ss}}$ is determined by synthesis–degradation balance. At $t=0$, a zero-order infusion starts that establishes and maintains a constant free drug concentration $C(t)=C_{0}$ for $t>0$. Define the receptor occupancy fraction as $O(t)=\\dfrac{RC(t)}{R(t)+RC(t)}$.\n\nStarting only from these fundamental kinetic definitions and the above system, explain how the receptor turnover rates $k_{\\text{syn}}$ and $k_{\\text{deg}}$ influence the characteristic time to approach the eventual occupancy $O(t)$ following the step to $C_{0}$. Then, suppose the infusion is stopped at $t=0$ and free drug is eliminated rapidly such that $C(t)\\approx 0$ for all $t>0$ (drug washout). Using the model, compute the time constant for recovery of $R(t)$ back toward $R_{\\text{ss}}$ after washout, expressed in hours, for a receptor with degradation rate $k_{\\text{deg}} = 0.062\\ \\text{h}^{-1}$.\n\nRound your final numerical answer to four significant figures. Express the time constant in hours.",
            "solution": "The problem asks for two distinct analyses of a standard Target-Mediated Drug Disposition (TMDD) model. First, a qualitative explanation of how receptor turnover rates influence the approach to a new steady state upon drug administration. Second, a quantitative calculation of the recovery time constant after drug washout.\n\nThe system of ordinary differential equations (ODEs) governing the concentrations of free receptor $R(t)$, free drug $C(t)$, and receptor-drug complex $RC(t)$ is given as:\n$$\n\\frac{dR}{dt} \\;=\\; k_{\\text{syn}} \\;-\\; k_{\\text{deg}}\\,R \\;-\\; k_{\\text{on}}\\,C\\,R \\;+\\; k_{\\text{off}}\\,RC\n$$\n$$\n\\frac{d(RC)}{dt} \\;=\\; k_{\\text{on}}\\,C\\,R \\;-\\; \\big(k_{\\text{off}} + k_{\\text{int}}\\big)\\,RC\n$$\nThe pre-drug steady state is characterized by $C(t)=0$, leading to $\\frac{dR}{dt} = k_{\\text{syn}} - k_{\\text{deg}}R = 0$, which gives the baseline receptor level $R_{\\text{ss}} = \\frac{k_{\\text{syn}}}{k_{\\text{deg}}}$. At this state, $RC(t)=0$.\n\n**Part 1: Influence of $k_{\\text{syn}}$ and $k_{\\text{deg}}$ on the time to reach occupancy steady state.**\n\nWhen a constant drug concentration $C(t) = C_0$ is established for $t>0$, the system dynamics for $R(t)$ and $RC(t)$ become a system of two linear, first-order, non-homogeneous ODEs. We can write this in matrix form. Let the state vector be $\\mathbf{x}(t) = \\begin{pmatrix} R(t) \\\\ RC(t) \\end{pmatrix}$. The system is $\\frac{d\\mathbf{x}}{dt} = A\\mathbf{x} + \\mathbf{b}$, where:\n$$\nA = \\begin{pmatrix} -(k_{\\text{deg}} + k_{\\text{on}}C_0) & k_{\\text{off}} \\\\ k_{\\text{on}}C_0 & -(k_{\\text{off}} + k_{\\text{int}}) \\end{pmatrix}, \\quad \\mathbf{b} = \\begin{pmatrix} k_{\\text{syn}} \\\\ 0 \\end{pmatrix}\n$$\nThe time evolution of the system from its initial state ($R(0)=R_{\\text{ss}}$, $RC(0)=0$) to the new steady state is governed by the eigenvalues of the matrix $A$. The characteristic times of the system are the negative reciprocals of these eigenvalues (assuming they are real and negative, which they are for a stable physical system).\n\nThe eigenvalues $\\lambda$ are the roots of the characteristic equation $\\det(A - \\lambda I) = 0$:\n$$\n\\det\\begin{pmatrix} -(k_{\\text{deg}} + k_{\\text{on}}C_0) - \\lambda & k_{\\text{off}} \\\\ k_{\\text{on}}C_0 & -(k_{\\text{off}} + k_{\\text{int}}) - \\lambda \\end{pmatrix} = 0\n$$\n$$\n\\big(\\lambda + k_{\\text{deg}} + k_{\\text{on}}C_0\\big)\\big(\\lambda + k_{\\text{off}} + k_{\\text{int}}\\big) - k_{\\text{on}}C_0 k_{\\text{off}} = 0\n$$\nExpanding this gives the characteristic polynomial:\n$$\n\\lambda^2 + \\big(k_{\\text{deg}} + k_{\\text{int}} + k_{\\text{on}}C_0 + k_{\\text{off}}\\big)\\lambda + \\big(k_{\\text{deg}}(k_{\\text{off}} + k_{\\text{int}}) + k_{\\text{on}}C_0 k_{\\text{int}}\\big) = 0\n$$\nThe characteristic times, which determine how quickly the system approaches its new steady state (and thus how quickly the occupancy $O(t) = \\frac{RC(t)}{R(t)+RC(t)}$ approaches its new equilibrium value), depend on the coefficients of this polynomial.\n\nInfluence of $k_{\\text{syn}}$: The receptor synthesis rate $k_{\\text{syn}}$ does not appear in the characteristic polynomial. It is part of the non-homogeneous term $\\mathbf{b}$. Therefore, $k_{\\text{syn}}$ affects the final steady-state concentrations of $R$ and $RC$ but does not affect the characteristic times governing the approach to that steady state.\n\nInfluence of $k_{\\text{deg}}$: The receptor degradation rate $k_{\\text{deg}}$ appears in both the linear and constant coefficients of the characteristic polynomial. An increase in $k_{\\text{deg}}$ leads to an increase in both of these positive coefficients. For a quadratic equation $\\lambda^2+b\\lambda+c=0$ with positive coefficients, increasing $b$ and $c$ shifts the roots (the eigenvalues) to be more negative (i.e., their magnitudes increase). The characteristic times are $\\tau_i = -1/\\lambda_i$. Larger magnitude eigenvalues correspond to smaller (shorter) characteristic times. Thus, a larger $k_{\\text{deg}}$ results in a faster approach to the new steady-state occupancy. Intuitively, $k_{\\text{deg}}$ represents the intrinsic turnover rate of the receptor. A faster turnover (higher $k_{\\text{deg}}$) allows the entire receptor system to adapt and re-equilibrate more quickly in response to the perturbation caused by the drug.\n\n**Part 2: Time constant for recovery after drug washout.**\n\nIn this scenario, we consider that after reaching a steady state with drug, the drug is washed out at $t=0$, so $C(t) \\approx 0$ for $t>0$. The governing ODEs become:\n$$\n\\frac{d(RC)}{dt} = - \\big(k_{\\text{off}} + k_{\\text{int}}\\big)RC\n$$\n$$\n\\frac{dR}{dt} = k_{\\text{syn}} - k_{\\text{deg}}\\,R + k_{\\text{off}}\\,RC\n$$\nLet's analyze the recovery process. The first equation is a simple homogeneous first-order ODE for $RC(t)$. Its solution is:\n$$\nRC(t) = RC(0) \\exp\\left(-\\left(k_{\\text{off}} + k_{\\text{int}}\\right)t\\right)\n$$\nwhere $RC(0)$ is the complex concentration at the moment of washout. This shows that the complex decays exponentially with a time constant $\\tau_{RC} = \\frac{1}{k_{\\text{off}} + k_{\\text{int}}}$.\n\nSubstituting this solution into the equation for $R(t)$:\n$$\n\\frac{dR}{dt} + k_{\\text{deg}}\\,R = k_{\\text{syn}} + k_{\\text{off}}\\,RC(0) \\exp\\left(-\\left(k_{\\text{off}} + k_{\\text{int}}\\right)t\\right)\n$$\nThis is a linear first-order non-homogeneous ODE. The solution for $R(t)$ will be a sum of the homogeneous solution, which decays as $\\exp(-k_{\\text{deg}}t)$, and a particular solution driven by the forcing term, which decays as $\\exp(-(k_{\\text{off}} + k_{\\text{int}})t)$. The full solution for $R(t)$ as it recovers to the baseline steady state $R_{\\text{ss}} = k_{\\text{syn}}/k_{\\text{deg}}$ is of the form:\n$$\nR(t) = R_{\\text{ss}} + A \\exp(-k_{\\text{deg}}t) + B \\exp(-(k_{\\text{off}} + k_{\\text{int}})t)\n$$\nwhere $A$ and $B$ are constants depending on the initial conditions.\n\nThe recovery of $R(t)$ is therefore a bi-exponential process, characterized by two time constants:\n1. $\\tau_{\\text{turnover}} = \\frac{1}{k_{\\text{deg}}}$, related to the intrinsic receptor synthesis and degradation.\n2. $\\tau_{\\text{binding}} = \\frac{1}{k_{\\text{off}} + k_{\\text{int}}}$, related to the dissociation and clearance of the drug-receptor complex.\n\nThe problem asks for \"the time constant\" for recovery and provides a value only for $k_{\\text{deg}}$. This implies a separation of timescales, a common situation in pharmacology where receptor turnover is significantly slower than binding/unbinding and internalization kinetics. That is, $k_{\\text{deg}} \\ll k_{\\text{off}} + k_{\\text{int}}$, which means $\\tau_{\\text{turnover}} \\gg \\tau_{\\text{binding}}$.\n\nUnder this assumption, the recovery consists of a fast initial phase where the complex $RC$ disappears (governed by $\\tau_{\\text{binding}}$), followed by a much slower phase where the free receptor pool $R$ is replenished back to its baseline $R_{\\text{ss}}$ (governed by $\\tau_{\\text{turnover}}$). The overall time to full recovery is dominated by this slower, rate-limiting step. Therefore, the characteristic time constant for the recovery of $R(t)$ is $\\tau_{\\text{turnover}}$.\n\nWe can now compute this time constant.\nGiven the degradation rate constant $k_{\\text{deg}} = 0.062 \\text{ h}^{-1}$.\nThe time constant $\\tau$ is the reciprocal of the rate constant:\n$$\n\\tau = \\frac{1}{k_{\\text{deg}}} = \\frac{1}{0.062 \\text{ h}^{-1}}\n$$\n$$\n\\tau = 16.129032... \\text{ h}\n$$\nRounding to four significant figures, we get:\n$$\n\\tau \\approx 16.13 \\text{ h}\n$$",
            "answer": "$$\n\\boxed{16.13}\n$$"
        }
    ]
}